The ALL-Rise study uses pictures obtained during an angiography to measure how much a narrow heart artery is affecting blood flow. This measurement (called Fractional Flow Reserve or FFR), helps your doctor decide if your heart blockage should be treated with medicine, or a surgical procedure and medicine. FFR is currently measured using a wire inserted into the blocked artery. The hope is that this study will prove that FFR can measured just as accurately in a noninvasive way.
The primary objective of this trial is to test whether FFRangio®-guided treatment is non-inferior to conventional pressure wire-guided treatment in participants with coronary artery disease being evaluated for percutaneous coronary intervention (PCI).
Inclusion Criteria-including but may not be limited to:
Adult participants (≥18 years of age) presenting with chronic coronary syndrome (CCS) or Non ST-elevation acute coronary syndrome (NSTEACS) with a study lesion(s) deemed appropriate for both pressure-wire and FFRangio assessment.
Please contact the Network Office of Research and Innovation at 610-402-9543.
https://clinicaltrials.gov/study/NCT05893498?term=ffrangio&rank=3
1250 S Cedar Crest Blvd
Suite 300
Allentown, PA 18103-6381
United States
3371 Route 100
Suite 305
Macungie, PA 18062-9613
United States